Sara Kazempour-Ardebili
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Sara Kazempour-Ardebili has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
Andrew H. Frankel
Imperial College Kidney and Transplant Institute, Division of Medicine, Hammersmith Hospital, London, U.K.
2 shared publicationsAnne Dornhorst
Department of Medicine, Imperial College London, Hammersmith Campus, London, U.K.
2 shared publicationsFrederick W.K. Tam
Imperial College Kidney and Transplant Institute, Division of Medicine, Hammersmith Hospital, London, U.K.
2 shared publicationsGary Frost
Department of Investigative Medicine, Imperial College London, Hammersmith Campus, London, U.K.
2 shared publicationsJeremy J.O. Turner
Department of Investigative Medicine, Imperial College London, Hammersmith Campus, London, U.K.
2 shared publicationsThushara Dassanyake
Imperial College Kidney and Transplant Institute, Division of Medicine, Hammersmith Hospital, London, U.K.
2 shared publications
Latest Publications
- Open Access
- 1 December 2009
- Published by American Diabetes Association in Diabetes Care
- Vol. 32 (12) , e156
Assessing Glycemic Control in Maintenance Hemodialysis Patients With Type 2 Diabetes
- 1 December 2009
- Published by American Diabetes Association in Diabetes Care
- Vol. 32 (12) , e156
Open AccessAssessing Glycemic Control in Maintenance Hemodialysis Patients With Type 2 Diabetes
- Open Access
- 1 July 2009
- Published by American Diabetes Association in Diabetes Care
- Vol. 32 (7) , 1137-1142
Assessing Glycemic Control in Maintenance Hemodialysis Patients With Type 2 Diabetes
OBJECTIVE: Optimizing glycemic control in diabetic patients undergoing maintenance hemodialysis requires accurate assessment. We hypothesize that 1) 48-h continuous glucose monitoring (CGM) provides additional, clinically relevant, information to that provided by the A1C measurement and 2) glycemic profiles differ significantly between day on and day off dialysis. RESEARCH DESIGN AND METHODS: With the use of GlucoDay S, 48-h CGM was performed in 19 type 2 diabetic subjects undergoing hemodialysis to capture consecutive 24-h periods on and off dialysis. Energy intake was calculated using food diaries. A1C was assayed by a high-performance liquid chromatography method. RESULTS: CGM data were available for 17 subjects (13 male) with a mean (range) age of 61.5 years (42–79 years) and diabetes duration of 18.8 years (4–30 years). The 24-h CGM area under the glucose curve and 24-h mean glucose values were significantly higher during the day off dialysis than on dialysis (5,932.1 ± 2,673.6 vs. 4,694 ± 1,988.0 mmol · 3 min−1 · l−1, P = 0.022, and 12.6 ± 5.6 vs. 9.8 ± 3.8 mmol/l, P = 0.013, respectively), independent of energy intake. Asymptomatic hypoglycemia occurred in 4 subjects, 3 within 24 h of dialysis, and the glucose nadir in 14 subjects occurred within 24 h of dialysis. CONCLUSIONS: Glucose values are significantly lower on dialysis days than on nondialysis days despite similar energy intake. The risk of asymptomatic hypoglycemia was highest within 24 h of dialysis. Physicians caring for patients undergoing hemodialysis need to be aware of this phenomenon and consider enhanced glycemic monitoring after a hemodialysis session. CGM provides glycemic information in addition to A1C, which is potentially relevant to clinical management.
- 1 July 2009
- Published by American Diabetes Association in Diabetes Care
- Vol. 32 (7) , 1137-1142
Open AccessAssessing Glycemic Control in Maintenance Hemodialysis Patients With Type 2 Diabetes
OBJECTIVE: Optimizing glycemic control in diabetic patients undergoing maintenance hemodialysis requires accurate assessment. We hypothesize that 1) 48-h continuous glucose monitoring (CGM) provides additional, clinically relevant, information to that provided by the A1C measurement and 2) glycemic profiles differ significantly between day on and day off dialysis. RESEARCH DESIGN AND METHODS: With the use of GlucoDay S, 48-h CGM was performed in 19 type 2 diabetic subjects undergoing hemodialysis to capture consecutive 24-h periods on and off dialysis. Energy intake was calculated using food diaries. A1C was assayed by a high-performance liquid chromatography method. RESULTS: CGM data were available for 17 subjects (13 male) with a mean (range) age of 61.5 years (42–79 years) and diabetes duration of 18.8 years (4–30 years). The 24-h CGM area under the glucose curve and 24-h mean glucose values were significantly higher during the day off dialysis than on dialysis (5,932.1 ± 2,673.6 vs. 4,694 ± 1,988.0 mmol · 3 min−1 · l−1, P = 0.022, and 12.6 ± 5.6 vs. 9.8 ± 3.8 mmol/l, P = 0.013, respectively), independent of energy intake. Asymptomatic hypoglycemia occurred in 4 subjects, 3 within 24 h of dialysis, and the glucose nadir in 14 subjects occurred within 24 h of dialysis. CONCLUSIONS: Glucose values are significantly lower on dialysis days than on nondialysis days despite similar energy intake. The risk of asymptomatic hypoglycemia was highest within 24 h of dialysis. Physicians caring for patients undergoing hemodialysis need to be aware of this phenomenon and consider enhanced glycemic monitoring after a hemodialysis session. CGM provides glycemic information in addition to A1C, which is potentially relevant to clinical management.